|
|
|
|
 Mr Peter Kash,
President Riverbank Capital Securities, United States of America Mr. Kash is a co-founder and President of Riverbank Capital Securities, Inc. In the last 20 years he has raised over 1 billion dollars for biopharmaceutical companies. He currently serves as Chairman of the Board of Directors of Nile Therapeutics, Inc. and as a director of Arno Therapeutics, Inc. He has co-founded more than a dozen biotech companies.
Mr. Kash served as an Adjunct Professor of Entrepreneurship and International Venture Capital at the Wharton School of Business at the University of Pennsylvania from 1996-2000. He was a Visiting Professor of Entrepreneurship at the Graduate School of Business at Nihon University in Tokyo 2000-2002. He was also Entrepreneur in Residence at Pace University and at Ball State University Mr. Kash served as a Professor of Entrepreneurship at the Sy Syms School of Business from 2003-2005, as well. He is also the author of three books, two of which were international best sellers: Make Your Own Luck (2001 Prentice Hall), published in 8 languages sold in over 35 countries worldwide, Freedom From Disease (2008 - St. Martin's Press) and Restart: Life Tactics for Todays Economy (2009- White River Press).
Peter has lectured and travelled to 60 countries discussing the future of biotech and the history of Entrepreneurship. He earned his B.S. in Management Science from S.U.N.Y. Binghamton and his M.B.A. in Banking and International Finance from Pace University. Peter has completed post graduate courses Making Boards of Directors both for profit and non-for profit more effective at Harvard Business School in He has completed his doctoral studies in education is currently completing his doctoral thesis of Education at the Azrieli Graduate School.
Peter was the 2008 co-honoree of the Childrens Brain Tumor Foundation, and currently serves on the several non-for-profit boards including Cancer Schmancer (womens cancer advocacy group), Founding-President of the Clarkstown Education Foundation serving 9,000 students.Appearing: Conference Day One: Wednesday, 17 March 2010 09.00 Cultivating entrepreneurships in biopharmaceutical industry of Asia and beyondEntrepreneurship, whether being a start-up or within an organization, is a key driver of our economy. Wealth and a high majority of jobs are created by small businesses started by entrepreneurially minded individuals, many of whom go on to create big businesses. Gearing up for a global gravity shift towards Asia, biopharma entrepreneurs are facing a wealth of opportunities. What are the success factors that Asia’s emerging biopharma business leaders employ to capture the growth of the industry? Find out the trade secrets when we take you through the journey of entrepreneurship with the most successful entrepreneurs from Asia
- The promises and challenges of Asia’s biopharmaceutical market in an era of healthcare reform
- Looking into the business opportunities in Asia to drive growth and global expansion for Asian and global players
- Finding the right business model and strategy to achieve success in the Asian and global biopharmaceutical arena
Mr Peter Kash,
(Moderator) President,
Riverbank Capital Securities, United States of America Chairman,
Given Imaging, Chairman, Netafim, Former President and Chief Executive Officer, Teva Pharmaceutical , Israel Founder, Chairperson & Managing Director,
Avesthagen Limited, India |
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
|
|
|
|
|
|
